Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis - Test2 - elhamkhani - TriplyDB

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

http://www.wikidata.org/entity/Q24683896

about

Effects of simulated altitude (normobaric hypoxia) on cardiorespiratory parameters and circulating endothelial precursors in healthy subjects VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex Radioresistance of Brain Tumors Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms MET: a critical player in tumorigenesis and therapeutic target Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.Cooperation between c-Met and focal adhesion kinase family members in medulloblastoma and implications for therapy.An orally bioavailable c-Met kinase inhibitor potently inhibits brain tumor malignancy and growth.microRNA-34a is tumor suppressive in brain tumors and glioma stem cells.XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLC.MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor.Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapy Regulatory mechanisms of testosterone-stimulated song in the sensorimotor nucleus HVC of female songbirds.Therapeutic strategies for inhibiting invasion in glioblastoma.Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility.Progress on antiangiogenic therapy for patients with malignant glioma.Experimental approaches for the treatment of malignant gliomas.Expression of hepatocyte growth factor and its receptor c-Met in human pituitary adenomas Development of c-MET pathway inhibitors.Non-agonistic bivalent antibodies that promote c-MET degradation and inhibit tumor growth and others specific for tumor related c-MET.Inhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in Medulloblastoma Glial progenitors as targets for transformation in glioma.Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex.Profiling the dynamics of a human phosphorylome reveals new components in HGF/c-Met signaling.Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors.The MET gene is a common integration target in avian leukosis virus subgroup J-induced chicken hemangiomas.The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.The HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy.Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma.Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro.Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas.EGFR and c-Met Cross Talk in Glioblastoma and Its Regulation by Human Cord Blood Stem Cells

P2860

Q21284409-5F1FC49C-0FA6-40B3-948F-A4BDC099A58A Q24293027-FFEA8459-18D8-4E97-AC76-738675DF8916 Q26752579-2A1D30B0-F7AC-42D2-9897-191634095336 Q26778929-4EBFB012-AECC-4DE9-AEC3-6AEBD7418F14 Q27008925-293372DB-D529-4BE5-A7DC-9F51F9B3F253 Q27011423-B3AD1BD2-E1AF-4C8B-8857-65E567EB41AD Q27021470-63638D9C-94C7-422B-BE0B-4227F84310FD Q30278053-6CE372FB-78D8-4910-94E2-4E03332073DC Q30405446-03B0E9B6-022A-4049-B3CB-B06EF382E609 Q30414321-683B6007-4675-42B9-BDD0-20320C0384A5 Q30422676-FA86766C-58B0-4D85-8A92-2E3FF86FD560 Q30428363-E5897DD0-1A3E-4EE0-87BD-BBF392402A34 Q30428366-A0DD9A49-9E50-4BA6-9CD9-2F13BF2024CB Q30428632-C387B84D-AAB9-4664-A39B-7D1F455E5C48 Q30434616-79F89EDF-29D9-4B6E-91F8-05DDE83307A6 Q30436756-C101D9B3-767B-4504-A184-15E0B8AA93C5 Q30437740-03FFC0EA-7584-46B1-86CE-21F49F209961 Q30606953-5A8514DC-49EC-48F6-ABD4-CA6E1720D444 Q33426563-57770C6A-B25F-4A80-A5A7-BE3361F34206 Q33427809-532B7ABD-FDE8-442F-A525-03084C1106BE Q33615358-A7F5BC48-4381-46D7-85F4-CDCC2D8E109A Q33773189-37656A5F-542D-467D-8F7E-B9F432F2C155 Q34127138-A404B776-8731-4335-AA03-5FF47773CD86 Q34133016-12A4ED87-C8F0-4DAC-BDE0-A80FC7D1141C Q34198905-2B50C122-A800-4F7A-B292-20A4A26BF01A Q34236834-290E1F4C-98AB-4B50-A4FA-E7BB3F8AD046 Q34398276-490E73CC-2625-4FC4-951C-45B549B71B58 Q34735661-F8A17BCD-9C9B-46E8-8479-71A970DE9C12 Q34755802-86C18F6F-D9FA-42AE-932A-C4C9DBC6BB47 Q34983997-B27178D7-CB7D-4874-8D48-C0D0ED7783AB Q35153149-59BEEA4E-CA3A-4037-84CA-9F231C11B4F9 Q35488562-C4C02178-8EB7-4333-9A9F-4681B6C46653 Q35563524-3F227BA8-83EC-4EFA-A450-040177A3EC3D Q35740444-6231E2C4-B477-4768-8474-4DFA8633A26F Q35895174-11AD4035-6A2B-4B9F-AAF6-E608E9149209 Q35913662-2F0B3503-1893-4CD2-A2CB-593DC317D110 Q36103026-B2265D02-2A35-4063-A331-2B4F23EB6596 Q36249219-F9626005-91E7-46BE-BDBB-EA72CA9C548A Q36289595-85216EC6-69FB-4E35-896C-181BEF1A7600 Q36310662-8D7ABD2D-1277-445A-8942-547318F49F6E

P2860

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

http://www.wikidata.org/entity/Q24683896

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

@ast

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

@en

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

@nl

type

label

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

@ast

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

@en

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

@nl

prefLabel

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

@ast

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

@en

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

@nl

P1433

Q24683896-AC10BB26-BB07-4B8D-AA71-4E9D01A07373

P1476

Q24683896-8730C467-71FC-4970-91D2-0C59D6086677

P2093

Q24683896-D8242113-DB35-47E4-B5EF-CDF408EC836B

Q24683896-DBFFC618-672D-467B-919D-C54AD785EEC1

P2860

Q24683896-01422BAD-63DD-4058-B01F-8A311562C0BA

Q24683896-0275E2AE-D856-4819-8BE7-247885175588

Q24683896-0685D35B-23D8-48EE-982A-F8F879B10A77

Q24683896-162AFC6E-10B0-4736-B6BD-7F5AB73BC637

Q24683896-17AB0E26-895A-4680-B3CC-80D1274ABA93

Q24683896-18C9EFF7-1FC9-4AE8-9DB9-5A08595862E3

Q24683896-197D1917-DDCB-4675-802D-98F605D76B37

Q24683896-1A289F91-B4D4-4ECA-9768-BA06825677C0

Q24683896-252F3E86-3C28-4A9F-B704-DD9924DA2CFE

Q24683896-270EA31F-550F-485E-BD6B-A85A265EBE0B

P304

Q24683896-8CCD80C4-33F7-41C6-8DC1-75AE08FB0448

P31

Q24683896-7255A18A-6F14-4A97-995F-D8375A337A9D

P3181

Q24683896-83F86D4A-0672-45CD-BC7D-074198F586E4

P356

Q24683896-0344F191-E6D7-43E7-BAF3-C4776F54837E

P407

Q24683896-70671E09-F883-4DFB-8101-4F7838FA6329

P433

Q24683896-04042DB0-3578-4814-896A-E94787EBB879

P478

Q24683896-2D2F8AA6-DDA8-4A27-9740-2E1CF3A65F0F

P577

Q24683896-B85514F4-542B-49D4-8BDD-E09F40A7917F

P698

Q24683896-F033B49C-7D6C-4A5F-AD4B-E442F8BB4243

P921

Q24683896-6C05D139-6B4A-4157-86A4-1701E08CDBEB

P932

Q24683896-1ACEA9AE-BDE2-4E7A-9CFE-870A691ACB7A

P3181

P356

S1152851705000050

P1433

P1476

Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis

@en

P2093

John Laterra

http://www.w3.org/2001/XMLSchema#string

Roger Abounader

http://www.w3.org/2001/XMLSchema#string

P2860

Genes expressed in human tumor endothelium

Molecular cloning and expression of human hepatocyte growth factor

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models

Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells

Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII

NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics

A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo

Met, metastasis, motility and more

Induction of epithelial tubules by growth factor HGF depends on the STAT pathway

P304

436-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5000580

http://www.w3.org/2001/XMLSchema#string

P356

10.1215/S1152851705000050

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16212809

http://www.w3.org/2001/XMLSchema#string

P921

P932

1871724

http://www.w3.org/2001/XMLSchema#string